rilpivirine extended release (BRII-778)
/ Brii Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 08, 2022
Safety, Tolerability, and Pharmacokinetics of BRII-778, A Modified-Release Oral Formulation of Rilpivirine in Healthy Adult Subjects
(IDWeek 2022)
- No abstract available
Clinical • PK/PD data • Infectious Disease
1 to 1
Of
1
Go to page
1